ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
OS Therapies Incorporated

OS Therapies Incorporated (OSTX)

2.20
-0.32
(-12.70%)
Closed November 14 3:00PM
2.20
0.00
(0.00%)
After Hours: 5:51PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
2.20
Bid
-
Ask
-
Volume
42,949
2.14 Day's Range 2.7599
2.20 52 Week Range 4.90
Previous Close
2.52
Open
2.74
Last Trade
45
@
2.2
Last Trade Time
Average Volume (3m)
45,853
Financial Volume
US$ 103,249
VWAP
2.404

OSTX Latest News

OS Therapies to Present at The Spartan Capital Investor Conference

OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, today announced that Paul Romness, Chief...

Join OS Therapies’ Exclusive Live Investor Webinar and Q&A Session on October 30

OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate (ADC) biopharmaceutical company, is pleased to invite investors to...

OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors

Concurrently, the Company accepted the resignations of Dr. Colin Goddard and Mr. Joacim Borg OS Therapies (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and...

OS Therapies to Present at the LD Micro Main Event XVII

OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate biopharmaceutical company, today announces that Paul Romness...

OS Therapies to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), a clinical-stage immunotherapy and Antibody Drug Conjugate biopharmaceutical company, today announces that Paul Romness...

OS Therapies Announces Last Patient Enrolled in OST-HER2 Osteosarcoma Phase 2b Clinical Trial Completes Last Patient Visit

Company to ring Closing Bell at NYSE on Thursday, October 3, 2024 Interviews scheduled with Fintech.TV and Schwab Network OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), a...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.6-21.42857142862.82.94432.2201662.61004907CS
4-0.94-29.93630573253.143.152.2173222.75922433CS
12-1.99-47.49403341294.194.472.2458533.44730425CS
26-1.8-4544.92.21416433.72580939CS
52-1.8-4544.92.21416433.72580939CS
156-1.8-4544.92.21416433.72580939CS
260-1.8-4544.92.21416433.72580939CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
UAVSAgEagle Aerial Systems Inc
US$ 3.58
(122.36%)
165.02M
PLAGPlanet Green Holdings Corp
US$ 3.54
(18.39%)
567.1k
SLNDSouthland Holdings Inc
US$ 2.90
(16.00%)
93.92k
MINFT Limited
US$ 9.90
(15.79%)
147.29k
PLXProtalix BioTherapeutics Inc
US$ 1.405
(13.31%)
1.47M
CLDICalidi Biotherapeutics Inc
US$ 2.04
(-39.64%)
8.42M
FOXOFOXO Technologies Inc
US$ 0.67
(-27.17%)
12.61M
KULRKULR Technology Group Inc
US$ 0.395
(-20.14%)
10.93M
AIRIAir Industries Group
US$ 4.79
(-17.70%)
226.3k
LPALogistic Properties of the Americas
US$ 6.23
(-15.35%)
203.17k
UAVSAgEagle Aerial Systems Inc
US$ 3.58
(122.36%)
167.29M
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 29.60
(-0.30%)
68.99M
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 1.965
(0.26%)
68.64M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 6.08
(2.01%)
59.01M
TZADirexion Daily Small Cap Bear 3X Share New
US$ 11.41
(4.11%)
39.08M